A couple of months ago this little beauty looked to most like it would live out it's days as a penny stock. Unable to raise funds for a long delayed pivotal phase III trial, and struggling to avoid delisting and eviction, prospects looked bleak.
Things have changed. Now there are ample funds to launch phase III for Multikine; to pay for LEAPS research that could result in EUA for H1N1; and funds to pay for further development of a rheumatoid arthritis treatment that could soon bring a very lucrative global licensing agreement, which could lead to a general recognition that the potential of the LEAPS platform to produce blockbuster drugs for infectious and autoimmune diseases is enormous.
What's the downside here? I don't see it going below a buck. So from here, you might lose a quarter. What's the upside? You do your own math. I am not going anywhere, until I see how this plays out for at least the next three months.
You called me names. You called everyone names. Why because I bought low and sold high? Is that a flip flopper? If anyone listens to you they lose money. That's the bottom line. You aren't a moron. You are ignorant.
The price of this stock has dropped better than 10% over the past two days. What is going to prevent it from continuing to drift lower in the days and weeks ahead? Let's be realistic and not deceive ourselves. That's about as simple as it gets. SS